Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)

NCT01968668 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathies

Interventions

DRUG: BAY94-8862
DRUG: BAY94-8862
DRUG: BAY94-8862
DRUG: BAY94-8862
DRUG: BAY94-8862
DRUG: Placebo
DRUG: BAY 94-8862
DRUG: BAY 94-8862

Sponsor

Bayer